What the Mounjaro injection price really tells you

The range is wide, here is why that matters to your decision

Private Mounjaro pricing in the UK sits in a broad band because the dose you start on and the dose you eventually reach are different things. Eli Lilly's list price revision in September 2025 pushed the highest available dose from around £122 to roughly £330 per four-week pen at list level, and private providers price above or around that depending on their cost base and what they include. If you are weighing up a headline figure, the first question is which dose that figure refers to, the 2.5mg starter pen and a 15mg maintenance pen are not interchangeable, and the treatment journey runs through several steps in between.

NICE's appraisal of tirzepatide confirmed Mounjaro's clinical case for weight management in adults with a BMI of 35 or above alongside a weight-related condition, with lower thresholds applying for some ethnic backgrounds under NICE TA1026. Trial evidence from the SURMOUNT programme showed average weight reductions of around 20–21% at the highest dose over 72 weeks. That context matters when you are considering cost: this is not a short course. Most people taking Mounjaro for weight management are on it for months. If you are trying to get a clear picture of what the 5mg step costs specifically, our guide to the Mounjaro 5 mg price breaks that dose down in detail. Our Mounjaro UK price guide sets that out in more detail.

What the advertised price often leaves out

Headline prices in this market frequently exclude items that most patients consider essential. Consultation fees are the most common omission, some providers charge these separately, as a one-off or on every repeat order. Prescription charges, delivery fees, and aftercare support are others. A price that looks lean upfront can accumulate quickly once those add-ons appear at checkout. If a repeat order requires a new clinical review (as it should, for a prescription medicine), check whether that review costs extra or is built in.

The question of aftercare is worth pausing on. Mounjaro is titrated, which means your dose increases over time as your prescriber assesses your progress and tolerance. That is not a passive process. A provider without structured clinical support between orders is leaving a gap. When patients reach the mid-point of their titration schedule, understanding exactly what they will pay at that stage is important, and our breakdown of the Mounjaro 5mg price helps make that step predictable. If you are trying to weigh one Mounjaro pen price against another, the aftercare model is one of the most meaningful points of comparison, even though it rarely appears on the pricing page.

Where nume sits in this, plainly stated

We are not the cheapest option, and that is a deliberate choice. One transparent price at nume covers the consultation, the prescription, the treatment itself, and free next-working-day delivery by DPD. There is no subscription, no auto-renewal, and no hidden fees. Every repeat order goes back through a real clinician before we dispatch anything. If you place your order before noon on a working day and your prescriber approves it (which happens the same day when you are clinically suitable) the pen leaves our GPhC-registered pharmacy that afternoon.

Our prescribers, including our clinical team, review every consultation personally. A named clinician, not a scoring algorithm, reads your answers. For some patients that distinction is the whole point; for others it is simply reassuring to know it exists. Treatment pricing is shown on our consultation and treatment page, and the figure there is the figure you pay. If you want to understand how our approach compares to what else is available, our guide to finding well-priced Mounjaro covers what to look for.

Why cheapest is the wrong yardstick for a prescription medicine

The MHRA has been clear that Mounjaro and the wider class of GLP-1 medicines are prescription-only for a reason: they require clinical assessment and ongoing monitoring. The same regulator has documented the consequences of buying injectable weight-loss medicines from sellers operating outside the licensed supply chain, fake pens, some containing insulin, sold via social media and unverified websites. In October 2025 the MHRA raided the first illicit UK site producing counterfeit tirzepatide pens. You can report suspect sellers and unusual side effects at the MHRA's Yellow Card scheme.

A small monthly saving is not the right measure when the alternative is a product from an unverified source. Price matters, nobody disputes that. But for a medicine that requires refrigeration, comes from a licensed manufacturer, and changes the way your body processes appetite signals, the provenance of your supply and the quality of clinical oversight sitting behind it are the measures that actually keep you safe. You can verify any online pharmacy on the GPhC register before you hand over your details; it takes about thirty seconds and is worth doing. The context around Mounjaro's September 2025 price increase also explains the market shift that is driving some of the more aggressive low-price offers currently circulating.